PAMS
Pictet Asset Management (Switzerland)’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $379M | Sell |
1,075,836
-100,477
| -9% | -$35.4M | 0.45% | 53 |
|
|
2023
Q1 | $371M | Buy |
1,176,313
+201,301
| +21% | +$63.4M | 0.46% | 48 |
|
|
2022
Q4 | $282M | Buy |
975,012
+192,229
| +25% | +$55.5M | 0.41% | 59 |
|
|
2022
Q3 | $227M | Buy |
782,783
+59,632
| +8% | +$17.3M | 0.34% | 83 |
|
|
2022
Q2 | $204M | Sell |
723,151
-184,515
| -20% | -$52M | 0.28% | 104 |
|
|
2022
Q1 | $237M | Sell |
907,666
-304,653
| -25% | -$79.5M | 0.27% | 114 |
|
|
2021
Q4 | $266M | Buy |
1,212,319
+147,497
| +14% | +$32.4M | 0.27% | 107 |
|
|
2021
Q3 | $193M | Buy |
+1,064,822
| New | +$193M | 0.21% | 136 |
|